Healthcare Equipment and Supplies
Company Overview of BrainScope Company, Inc.
BrainScope Company, Inc., a neurotechnology company, develops tools to identify traumatic brain injuries. The company offers non-invasive instruments to aid medical professionals to aid in the assessment of brain function at the initial point of care. It provides its products for military use in the United States for the assessment of traumatically-induced head injury and concussions. The company was incorporated in 2006 and is based in Bethesda, Maryland.
8120 Woodmont Avenue
Bethesda, MD 20814
Founded in 2006
Key Executives for BrainScope Company, Inc.
Chief Executive Officer, President and Director
Vice President of Research and Development
Vice President of Clinical Affairs
Compensation as of Fiscal Year 2014.
BrainScope Company, Inc. Key Developments
Brainscope Co. Inc. Wins $9.94 Million Federal Contract
Sep 30 14
Brainscope Co. Inc. announced that it was awarded a $9,938,953 federal contract by the U.S. Army Contracting Command, Natick Division, Natick, Massachusetts, for research and development on the brain functions assessment of mild traumatic brain injury, from initial injury to rehabilitation and treatment.
BrainScope Company, Inc. Wins Three Contracts of $15.9 Million from United States Department of Defense
Sep 30 14
BrainScope(R) Company, Inc. announced that it has been awarded three contracts by the United States Department of Defense (DOD), both from the U.S. Army and Navy, for continued research and development of its Ahead(R) system for the assessment of Traumatic Brain Injury (TBI) and concussion. These three contracts combined are valued at $15.93 million. These newly awarded contracts will enable BrainScope to conduct further clinical studies and development of its TBI and concussion technology in hospital Emergency Departments and with university sports programs. From 2011 through 2013, BrainScope was awarded $11.27 million of DOD research contracts for the development of its TBI assessment technology, bringing the total awarded to date to $27.2 million. In addition, BrainScope has received significant funding from private investors to accelerate its development efforts. BrainScope's proprietary Ahead system in development addresses the unmet need for a medical device to aid in the evaluation of patients who are suspected of TBI, including its milder form known as concussion. The Ahead system records brain electrical activity with a handheld, non-invasive, non-radiation emitting medical device, and utilizes advanced algorithms that quantify and characterize features of brain electrical activity associated with TBI. The Ahead system is being developed to be utilized as an adjunct to standard clinical practice to aid in the rapid, effective and objective assessment of individuals suspected of TBI at the point of care. Early identification and categorization of even the mildest forms of brain injury are the first steps in providing proper care to ensure optimal recovery. BrainScope recently completed development of a prototype miniaturized Ahead system using existing smartphone technology that will be utilized under these three contracts.
BrainScope Company, Inc. Presents at The 7th Annual OneMedForum San Francisco 2014 Conference, Jan-13-2014
Dec 23 13
BrainScope Company, Inc. Presents at The 7th Annual OneMedForum San Francisco 2014 Conference, Jan-13-2014 . Venue: Westin San Francisco Market Street, San Francisco, California, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
August 5, 2014